Search

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

… Wednesday, January 28, 2015 Summary An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research. Memorial Sloan Kettering is pleased to share the news that the American Society of Clinical Oncology (ASCO) has recognized three of our recent studies

Researchers gain insight into leptomeningeal metastasis, a devastating complication of advanced cancer.

… Friday, July 17, 2020 Summary Cancer that has spread to the fluid and tissues of the brain and spinal cord, called leptomeningeal metastasis , is difficult to treat. It was not clear how the cancer cells survive in this space. A new discovery shows the cancer cells reprogram themselves to outcompete

Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of CRD3874-SI, Curadev’s first-in-class allosteric stimulator of interferon genes (STING) agonist for solid tumors.

… Friday, June 20, 2025 Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK Therapeutics Accelerator program to advance the development of CRD3874-SI, Curadev’s first-in-class

Minimally invasive techniques, improved postoperative care, and a multidisciplinary approach help make Memorial Sloan Kettering Cancer Center’s rates of esophageal surgical morbidity and mortality among the country’s lowest.

… Friday, September 23, 2016 At Memorial Sloan Kettering Cancer Center (MSK), we have made significant strides in the management of esophageal cancer over the past ten years. Improvements in postoperative care and the introduction of minimally invasive techniques have decreased the number of postoperative

The Lehigh Valley Health Network (LVHN) Cancer Institute is now a formal member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for people with cancer in community healthcare settings. Representatives of both organizations made the announcement today at Lehigh Valley Hospital–Cedar Crest following an intensive six-month collaborative review process.

… Tuesday, March 15, 2016 The Lehigh Valley Health Network (LVHN) Cancer Institute is now a formal member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for people with cancer in community healthcare settings. Representatives

Learn about a heartburn-related condition called Barrett’s esophagus and its connection to a higher risk of esophageal cancer.

… Friday, July 10, 2020 Summary People with chronic heartburn may have gastroesophageal reflux disease . This can develop into a condition called Barrett’s esophagus , which increases the risk of esophageal cancer. Barrett’s esophagus should be closely monitored, and in some cases treated, to reduce this

Prognostic genetic testing is recommended for all patients with chronic lymphocytic leukemia (CLL). However, recent research shows that testing is infrequently performed and outcomes poorer in patients with unfavorable disease risk.

… Tuesday, July 10, 2018 Prognostic genetic testing is recommended for all patients with chronic lymphocytic leukemia (CLL) to inform disease management and predict survival and disease progression. However, recent research shows that among almost 1,500 patients with CLL who were treated in a community

By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.

… Thursday, May 12, 2022 Daniel Heller holding a model of a nanosensor Biomedical engineer Daniel Heller leads the Cancer Nanomedicine Laboratory at MSK. Mijin Kim Kravis WiSE Postdoctoral Fellow Mijin Kim MSK surgeon Kara C. Long MSK surgeon Kara C. Long Lakshmi Ramanathan Lakshmi Ramanathan, Chief of

Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their latest research at the 65th American Society of Hematology (ASH) Annual Meeting, held in San Diego, December 9 to 12, 2023.

… Monday, December 11, 2023 Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their latest research at the 65 th American Society of Hematology (ASH) Annual Meeting, held in San Diego, December 9 to 12, 2023. Highlights included essential insights into managing and reducing treatment-related

Learn about 14 students who will receive doctoral degrees from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at MSK.

… Tuesday, May 28, 2019 Summary This week 14 students will receive doctoral degrees from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at Memorial Sloan Kettering (MSK). They are the largest group to graduate in a given year since the school was established in 2004. The innovative program